Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...

The FDA approval comes less than a week after it was announced by U.S. officials that booster shots will be needed for those who took the two-dose Pfizer or Moderna vaccine.

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines ...

Since 2020, investors have been rallying behind shares of Pfizer and Germany's BioNTech, two companies that were poised to play a crucial role in helping bring an end to a devastating pandemic.

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

FDA approves Pfizer’s eczema treatment New York City-based Pfizer earned approval from the Food and Drug Administration for its topical drug Eucrisa, reports Reuters.

The FDA granted full-approval to Pfizer’s meningococcal disease immunization, Penbraya, on Oct. 20. The new vaccine provides what Pfizer noted in a press release is the “broadest” protection ...